在World Science Day,Peter Hotez团队表示其低成本无专利COVID疫苗Corbevax和IndoVac已在印度和印尼覆盖1亿人,新的钩虫贫血疫苗临床试验显示高保护水平,希望加速推向非洲等地区。团队还优化mRNA技术与BCM Cancer Center合作推进乳腺癌和胰腺癌两款新疫苗/免疫疗法。
On this World #ScienceDay for Peace and Development our team of scientists at @TexasChildrens @BCM_TropMed are working to build on our earlier success of a low cost patent free COVID vaccine that reached 100 million people in India and Indonesia as Corbevax and IndoVac, respectively. Our new hookworm anemia vaccine is now showing high levels of protection in clinical trials and we hope to accelerate it as a new anemia vaccine for the African Continent and elsewhere. Now our scientists have refined the mRNA technology to work with our @BCMCancerCenter to advance two new vaccines/immunotherapies for breast and pancreatic cancers @mebottazzi
Our common future depends on sustainable funding for science. Tuesday is World #ScienceDay for Peace & Development, an opportunity to highlight the importance and relevance of science in society and our daily lives. https://www.un.org/en/observances/world-science-day在 X 查看被引用的帖子
来源:Prof Peter Hotez MD PhD DSc(hon) · x.com